Exchange: NYSEMkt·Updated 07:30 PM EDT
NRXS logo

NRXS Neuraxis Inc

$7.31
$0.02
(0.26%)
Today
Closed $7.61
$0.30
(3.94%)
After Hours
Mkt Cap$95.56M
Vol174,633.00

About NRXS

NeurAxis, Inc. engages in the provision of neuromodulation therapies to address chronic and debilitating conditions in children. Its product, IB-Stim, is a non-surgical device that works by sending gentle electrical impulses into cranial nerve bundles located in the ear. The company was founded by Gary Peterson and Christopher Robin Brown in 2011 and is headquartered in Carmel, IN.
59

Bullish Sentiment

How do you feel about NRXS?

Finnish_boy
$NRXS 19 million lives coverage. Earlier was 45 million. Great addition. Not sure will be there more this year. CEO comments have been confusing.
1
2
CBAZZ03
$NRXS This will most definetly be a solid long term stock, think about public reaction once this company hits profitability
1
1
DylanGFM
$NRXS not sure about more long-term buy and hold capability right now but it's at least having a start in intraday gains so far could have a decent scalp or two in it. Who knows, the market being this strong we could see a real nice move
1
1
Finnish_boy
$NRXS CEO told they are on the pace of 7-8M for full year. H1 was 3.55M. Lets use 8M. Then there will be 4.5M for H2. Q3: 2.0M and Q4: 2.5M Q3 earnings will be awful. Q4 starting point.
1
1
Finnish_boy
$NRXS "that research has allowed us to gain significant insurance policy coverage with significant more insurance policy coverage expected in the next 6 to 9 months." I will be back some day. I dont expect any new coverage this year. I am out.
1
Tennis_4567
$NRXS the insurance coverage they announced was Cigna. It was effective the day it was announced. I think at least one more major insurance win is announced this year. People aren't prepared for the kind of exponential revenue growth we're going to see next year
2
DylanGFM
$NRXS Right. I meant as far as from this exact day on I wouldn't want to buy and hold from here, prob wait till it gets a bit lower for the next long term move iup
1
JFais
$NRXS (NP) Interesting medical device play, neuromodulation for GI disorders (am a fan of non-drug options) Expanded coverage brings PENFS to >120M lives (caveat= hospitals can be slow adopters) Osmium (veteran in the space) w/few thoughts on CEO from ongoing Chat discussion
DylanGFM
$NRXS isn't looking too bad I made good money on it before and it surprisingly held a decent run up before New Year's and continued until May with a decent looking PR today

Advertisement|Remove ads.